title: Indications and guidelines for the use of hematopoietic growth factors.
authors.affiliation: Washington University School of Medicine, St. Louis, Missouri.
authors.forename: L T
authors.initials: LT
authors.lastname: Goodnough
authors.forename: K C
authors.initials: KC
authors.lastname: Anderson
authors.forename: S
authors.initials: S
authors.lastname: Kurtz
authors.forename: T A
authors.initials: TA
authors.lastname: Lane
authors.forename: P T
authors.initials: PT
authors.lastname: Pisciotto
authors.forename: M H
authors.initials: MH
authors.lastname: Sayers
authors.forename: L E
authors.initials: LE
authors.lastname: Silberstein
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy; D000740:Anemia / Q000209:etiology / Q000628:therapy; D016026:Bone Marrow Transplantation; D004921:Erythropoietin / Q000627:therapeutic use*; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D007938:Leukemia / Q000628:therapy; D009190:Myelodysplastic Syndromes / Q000628:therapy; D009369:Neoplasms / Q000628:therapy
chemical_list: D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor